Physician profile
Terry Hunt
NPI 1760447171
$1,160.78
in general payments reported to CMS, 2019-2025
17 companies · $90.58 in 2025
The $90.58 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.12 · 2020: $76.61 · 2021: $246 · 2022: $137 · 2023: $286 · 2024: $303 · 2025: $90.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $505.10 | 2021-2025 | |
| Pfizer INC. | $109.85 | 2019-2023 | |
| Glaxosmithkline, LLC. | $109.67 | 2022-2024 | Trelegy Ellipta |
| Abbott Laboratories | $72.99 | 2021-2024 | Freestyle Libre 3 |
| Sunovion Pharmaceuticals INC. | $61.68 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $59.69 | 2023-2024 | Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $46.80 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.99 | 2021-2022 | |
| Lilly USA, LLC | $25.11 | 2019-2023 | Jardiance |
| Phathom Pharmaceuticals, INC. | $24.22 | 2024 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $22.07 | 2022 | |
| Hologic Sales and Service, LLC | $21.95 | 2024 | Aptima |
| Astellas Pharma US INC | $15.57 | 2024 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.29 | 2024 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $14.85 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.50 | 2023 | Breztri |
| Exact Sciences Corporation | $14.45 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.